Position in AMGN
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$5,976,066
+$10,098 QoQ
Shares Held
16,503
-2.7% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.47%
of 13F equity value
Holder Rank
#751
of 3,140 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Penobscot Investment Management Company, Inc. holds $78,402,280 across 11 Drug Manufacturers - General names. AMGN ranks #5 (7.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
77,452 | $19,490,021 | |
| 2 | LLY |
ELI LILLY & Co
|
12,634 | $15,153,599 | |
| 3 | JNJ |
Johnson & Johnson
|
55,938 | $14,206,573 | |
| 4 | AZN |
Astrazeneca PLC
|
60,174 | $11,410,193 | |
| 5 | AMGN |
Amgen Inc
This page
|
16,503 | $5,976,066 | |
| 6 | NVS |
Novartis AG
|
26,577 | $4,165,147 | |
| 7 | MRK |
Merck & Co., Inc.
|
31,382 | $4,032,587 | |
| 8 | PFE |
Pfizer Inc
|
79,410 | $1,912,192 |
All Filings in AMGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,976,066 | 16,503 | Shares | Sole | 2026-07-24 | |
| 2026-03-31 | $5,965,968 | 16,956 | Shares | Sole | 2026-04-29 | |
| 2025-12-31 | $5,362,647 | 16,384 | Shares | Sole | 2026-01-27 | |
| 2025-09-30 | $4,736,444 | 16,784 | Shares | Sole | 2025-10-21 | |
| 2025-06-30 | $4,664,203 | 16,705 | Shares | Sole | 2025-07-22 | |
| 2025-03-31 | $4,997,885 | 16,042 | Shares | Sole | 2025-04-23 | |
| 2024-12-31 | $4,237,485 | 16,258 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $5,288,432 | 16,413 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $5,035,444 | 16,116 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $4,678,769 | 16,456 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $5,428,024 | 18,846 | Shares | Sole | 2024-02-05 | |
| 2023-09-30 | $5,124,446 | 19,067 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $4,045,425 | 18,221 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $4,589,865 | 18,986 | Shares | Sole | 2023-05-08 | |
| 2022-12-31 | $4,996,463 | 19,024 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $4,336,470 | 19,239 | Shares | Sole | 2022-11-02 | |
| 2022-06-30 | $4,688,146 | 19,269 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $4,641,009 | 19,192 | Shares | Sole | 2022-05-11 | |
| 2021-12-31 | $4,741,692 | 21,077 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $5,096,369 | 23,966 | Shares | Sole | 2021-11-08 | |
| 2021-06-30 | $7,626,937 | 31,290 | Shares | Sole | 2021-08-09 | |
| 2021-03-31 | $8,452,572 | 33,972 | Shares | Sole | 2021-05-07 | |
| 2020-12-31 | $7,754,051 | 33,725 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $8,408,374 | 33,083 | Shares | Sole | 2020-11-03 | |
| 2020-06-30 | $7,732,433 | 32,784 | Shares | Sole | 2020-08-04 | |
| 2020-03-31 | $6,697,793 | 33,038 | Shares | Sole | 2020-05-07 | |
| No filing history on record for this holder in this stock. | ||||||